Facultade de Ciencias
Fakultät
Instituto de Salud Carlos III
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Salud Carlos III (6)
2024
-
Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy
Journal of Experimental and Clinical Cancer Research, Vol. 43, Núm. 1
2023
-
Mitochondrial RNA methyltransferase TRMT61B is a new, potential biomarker and therapeutic target for highly aneuploid cancers
Cell Death and Differentiation, Vol. 30, Núm. 1, pp. 37-53
2021
-
Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug
Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1
-
The front labelling of food: Nutritional traffic lights, nutri-score and others
European Food and Feed Law Review, Vol. 16, Núm. 2, pp. 104-111
2002
-
Transient activation of the c-Jun N-terminal kinase (JNK) activity by ligation of the tetraspan CD53 antigen in different cell types
European Journal of Biochemistry, Vol. 269, Núm. 3, pp. 1012-1021
1996
-
CD53 antigen and epidermal growth factor induce similar changes in the pattern of phorbol ester binding in a B cell lymphoma
Cellular Immunology, Vol. 169, Núm. 1, pp. 107-112